83 related articles for article (PubMed ID: 133565)
1. [Experiences in the management of rheumatoid diseases using different clofezone doses].
Celik CM
Z Rheumatol; 1976; 35(5-6):240-7. PubMed ID: 133565
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis.
Brackertz D
Z Rheumatol; 1978; 37(9-10):342-9. PubMed ID: 153679
[TBL] [Abstract][Full Text] [Related]
3. [Long-term therapy of rheumatoid arthritis with perclusone].
Rejholec V
Z Rechtsmed; 1975; 34(5-6):141-8. PubMed ID: 132816
[TBL] [Abstract][Full Text] [Related]
4. Butazolidin suppository medication in rheumatism; a clinical study in general practice.
McIntosh IB
J Int Med Res; 1977; 5 Suppl 2():81-4. PubMed ID: 303188
[TBL] [Abstract][Full Text] [Related]
5. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)].
Reinicke C; Helbing M; Klingenfeld U; Lasaroff I; Wessel G
Pharmazie; 1984 Dec; 39(12):824-7. PubMed ID: 6241720
[TBL] [Abstract][Full Text] [Related]
6. [Our 1st experiences with Butazolidin Alka 100 tablets].
Franović A
Reumatizam; 1974 Jan; 21(1):8-10. PubMed ID: 4594966
[No Abstract] [Full Text] [Related]
7. A controlled comparative trial of Butacote and fenclofenac in the treatment of ankylosing spondylitis.
Thompson M; Akyol MS
J Int Med Res; 1977; 5 Suppl 2():96-9. PubMed ID: 334611
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
Mizushima Y; Shiokawa Y; Honma M; Kageyama T
Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
[TBL] [Abstract][Full Text] [Related]
9. [Value of clofezone in the treatment of rheumatic diseases].
Stroescu I; Stoicescu M; Dragomir M; Burtea A; Pintea G; Stoia I
Schweiz Rundsch Med Prax; 1971 Feb; 60(7):217-20. PubMed ID: 5555631
[No Abstract] [Full Text] [Related]
10. Butacote and ibuprofen: a comparative assessment in rheumatic diseases in general practice.
Regalado RG
J Int Med Res; 1977; 5 Suppl 2():70-6. PubMed ID: 334608
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of ibuprofen and phenylbutazone in a short-term treatment of rheumatoid arthritis.
Pavelka K; Susta A; Vojtísek O; Brémová A; Kanková D; Hándlová D; Malecek J
Arzneimittelforschung; 1973 Jun; 23(6):842-6. PubMed ID: 4579953
[No Abstract] [Full Text] [Related]
13. [Clofezone, a new potent antirheumatic drug].
Kaiser H
Munch Med Wochenschr; 1973 Dec; 115(49):2247-8. PubMed ID: 4205416
[No Abstract] [Full Text] [Related]
14. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study with a new phenylbutazone preparation in rheumatology].
Marmont A; Rossi F
Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104
[No Abstract] [Full Text] [Related]
16. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
17. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
[TBL] [Abstract][Full Text] [Related]
18. Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
Rivera IC
Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477
[TBL] [Abstract][Full Text] [Related]
19. [Sulfasalazine in rheumatoid arthritis].
Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
[TBL] [Abstract][Full Text] [Related]
20. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
